arrow
J

Joana Vidal

Hospital del Mar
H指数:19
被引数:1,665

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Irreversible electroporation for liver metastases not amenable to conventional treatments, an experience with technical challenges, clinical outcomes, and complications

不可逆电穿孔治疗无法通过常规治疗的肝脏转移瘤:一项关于技术挑战、临床结果和并发症的研究

2026-10-090
OAAI
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

循环肿瘤DNA指导的高风险II期和III期结肠癌辅助治疗降级或升级:PEGASUS II期试验

2026-09-140
OAAI
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study

液体活检-实体瘤治疗反应评价标准(LB-RECIST)在转移性结直肠癌(mCRC)患者中的临床验证:PLATFORM-B研究的结果

2025-09-030
OAAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer

在癌症实验模型中,通过定制的化学诱变诱导错配修复缺陷型基因型

2025-06-120
PRE
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives

结直肠癌腹膜癌病的液体活检:当前证据与未来展望

CANCERS
IF4.4
2025-04-260
OA
Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study

抗生素使用与切除的结直肠癌患者复发之间的关联: EVADER-1,一项全国性的药物流行病学调查

2025-01-010
PRE
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)

恩科非尼和比尼美替尼联合放疗治疗BRAFV600-mutant黑色素瘤和脑转移患者 (e-brain/GEM1802 II期研究)

2024-07-010
OAAI
Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study
2022-06-018
OA
Prevalence of functional and genomic homologous recombination deficiency (HRD) in germline RAD51C/D patients
2022-05-010
OAAI